EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Delisted

EUCRW was delisted on the 26th of April, 2023.

19 hedge funds and large institutions have $2.4M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
EC
1
EcoR1 Capital
California
$651K 66,666
AA
2
AQR Arbitrage
Connecticut
$447K 45,832
RCM
3
Radcliffe Capital Management
Pennsylvania
$325K 33,333
DM
4
Deerfield Management
New York
$193K 333,333 +333,333 New
BlackRock
5
BlackRock
New York
$173K 300,044 -8,289 -3%
6CM
6
683 Capital Management
New York
$116K 200,000
CAC
7
Cowen and Company
New York
$103K 178,347 +140,869 +376%
ACM
8
Altium Capital Management
New York
$77K 133,333
GPCM
9
Granite Point Capital Management
Massachusetts
$77K 133,332
CH
10
CVI Holdings
Delaware
$69K 118,333
HM
11
HealthCor Management
New York
$45K 78,059 +78,059 New
KCM
12
Kingdon Capital Management
New York
$36K 66,665
RCM
13
Rivernorth Capital Management
Florida
$19K 33,332
SCM
14
Suvretta Capital Management
New York
$19K 33,333
Jane Street
15
Jane Street
New York
$15K 26,600 -40 -0.2%
GCL
16
Glazer Capital LLC
New York
$15K 25,084 +25,084 New
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$13K 22,697
SC
18
Sagefield Capital
Texas
$2K 2,666 +2,666 New
Morgan Stanley
19
Morgan Stanley
New York
$1K 1,300
MIM
20
Monashee Investment Management
Massachusetts
-99,998 Closed
UBS Group
21
UBS Group
Switzerland
-1,175 Closed
CFGS
22
Concourse Financial Group Securities
Alabama